Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07791940
PHASE4

Effect of Rifaximin on Thrombocytopenia in Patients With HCV-Related Liver Cirrhosis

Sponsor: Fayoum University Hospital

View on ClinicalTrials.gov

Summary

Cirrhosis is a common complication of chronic hepatitis C virus (HCV) infection in Egypt. Thrombocytopenia (TP) is the most common cytopenia in patients with cirrhosis and may be associated with variceal bleeding, rebleeding, morbidity, and mortality. Although TP has traditionally been attributed to portal hypertension and splenic sequestration, other mechanisms include impaired thrombopoietin activity, bone marrow suppression, and increased platelet destruction. Rifaximin is a poorly absorbed, broad-spectrum intestinal antimicrobial agent widely used in patients with cirrhosis, particularly for hepatic encephalopathy. Its minimal systemic absorption limits systemic adverse effects. Rifaximin may reduce intestinal bacterial overgrowth and bacterial translocation, thereby decreasing circulating endotoxin and proinflammatory cytokines that may contribute to haematological abnormalities in cirrhosis. Previous observations have suggested that intestinal decontamination with rifaximin may increase platelet counts in patients with cirrhosis and thrombocytopenia. This randomised controlled trial was designed to investigate whether rifaximin treatment could improve platelet count in patients with HCV-related liver cirrhosis and thrombocytopenia.

Official title: Evaluation of the Role of Rifaximin on Thrombocytopenia in Patients With Hepatitis C-Related Liver Cirrhosis

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

165

Start Date

2015-10-19

Completion Date

2016-12-30

Last Updated

2026-08-28

Healthy Volunteers

No

Interventions

DRUG

Rifaximin (drug)

Rifaximin 550 mg tab twice daily for four weeks

OTHER

Rifaximin Placebo

Twice daily for 4 weeks

Locations (2)

Faculty of Medicine, Fayoum University Hospital

Al Fayyum, Egypt

Faculty of Medicine, Beni Suef University Hospital

Banī Suwayf, Egypt